ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 155 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2024. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,397 | -17.2% | 16,395 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $43,939 | -39.8% | 16,395 | -32.8% | 0.00% | -50.0% |
| Q4 2023 | $72,950 | +144.0% | 24,398 | -20.0% | 0.00% | +100.0% |
| Q3 2023 | $29,892 | +69.5% | 30,502 | +175.0% | 0.00% | 0.0% |
| Q1 2023 | $17,636 | -74.9% | 11,092 | -1.7% | 0.00% | -66.7% |
| Q4 2022 | $70,293 | – | 11,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |